In honour of International Women’s Day 2024, observed on March 8th, the EHC Women and Bleeding Disorders Committee is pleased to present its 7-2-1 rule infographic.
Heavy menstrual bleeding is one of the primary symptoms of women affected by rare bleeding disorders and it can have a severe impact on daily quality of life. However, many women are still unaware of how heavy their periods are and whether they should seek medical help. This meticulously crafted graphic illustrates the 7-2-1 rule, a vital guideline for recognising signs of heavy periods.
Below is the original English version and other languages in which the flyer has already been translated. Furthermore, we offer a customisable version of the infographic, facilitating dissemination among our esteemed EHC members for localisation in various languages. We hope that this resource will serve as a valuable tool not only within our community but also among clinicians and other healthcare professionals dedicated to the well-being of women and girls affected by bleeding disorders.
We strongly encourage members of our community to use these infographics freely and tailor them to their country’s needs, for instance, by adding the contact details of their National Member Organisation (NMO) or women’s group.
The EHC Women and Bleeding Disorders Committee is steadfast in its belief that such initiatives play a pivotal role in fostering awareness and understanding within our community. By leveraging this tool, we endeavour to advocate for early recognition, timely and accurate diagnosis, and improved treatment and care for women and girls impacted by these conditions.
Let us unite on March 8th, amplifying our efforts to raise awareness and advocate for enhanced support systems. Together, let us empower women and girls on the occasion of Women’s Day!
Download the 7-2-1 rule infographic
Square infographics are well-suited for Instagram and Facebook, while horizontal infographics are more suitable for Twitter and LinkedIn. PDF documents are also available for professional printing.
- English: square – horizontal – pdf
- French: square – horizontal – pdf
- German: square – horizontal – pdf
- Portuguese: square – horizontal – pdf
- Spanish: square – horizontal – pdf
- Italian: square – horizontal – pdf
- Russian: square – horizontal – pdf
- Hungarian: square – horizontal – pdf
- Serbian: square – horizontal – pdf
- Dutch: square – horizontal – pdf
- Slovenian: square – horizontal – pdf
- Blank (template): square – horizontal – pdf
Disclaimer: This infographic is for information only and should not be used in place of referral and diagnosis by a healthcare professional. If you experience one or more of these symptoms, talk to your doctor or other healthcare professional.
Further resources to assess heavy menstrual bleeding can be found on this page.
Jim is aged 66 and has Haemophilia A with a high titer inhibitor which he developed at age 14.
Maria Elisa Mancuso (MD, PhD) is a Haematologist and works as a Senior Haematology Consultant at the Center for Thrombosis and Haemorrhagic Diseases of IRCCS Humanitas Research Hospital in Rozzano, Milan, Italy. She is Adjunct Clinical Professor at Humanitas University. She obtained a post-degree in Clinical and Experimental Haematology and a PhD in Clinical Methodology. She is involved in clinical research and has published several original articles in peer-reviewed journals a The Lancet, Blood, Journal of Thrombosis and Haemostasis, Haematologica, Thrombosis and Haemostasis, British Journal of Haematology and Haemophilia. She is reviewer for several peer-reviewed journals and member of the Editorial Board of JTH. She is a member of several scientific societies (ISTH, WFH, ASH, EAHAD, SISET, AICE) and was a medical member of the Inhibitor Working Group of the European Hemophilia Consortium. She is co-chair of the ADVANCE Study Group. She has acted also as co-chair of the Scientific and Standardization Subcommittee of ISTH on FVIII, FIX and rare bleeding disorders. She has been involved as principal and co-investigator in several clinical trials, and she takes care of both children and adults with hemophilia and other congenital bleeding disorders with a specific scientific interest in novel therapies, prophylaxis, inhibitors, and chronic hepatitis C.
As a patient with factor II deficiency, the diagnostic and treatment of rare bleeding disorders is a matter dear to my heart. My motivation to participate in the work of the ERIN committee is to improve both diagnostic and treatment for patients with rare bleeding disorders across Europe.
Economist and financial expert by profession, executive coach and trainer by passion and haemophilia advocate by every drop of my blood through my son (who has severe haemophilia A with inhibitors). Bringing a good decade of practical experience from the corporate insurance world, laser focus, growth mindset and resilience from my own experience, offering you anything I can just do, in hope that together we can make life more fulfilled for those impacted by bleeding disorders.
Amy Owen-Wyard is a Registered Mental Health Nurse. With experience working with children, young people, their families and adults with severe and enduring mental health conditions. Amy was also involved in a service improvement to provide a holistic care approach for those in general hospitals to support both their mental and physical health, whilst sharing her expertise and knowledge in mental health with the wider multidisciplinary team.
